Cellingbiosciences.com Website Review

Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows a user to regulate and select a desired cell type through a patented collection The ART PLUS Family of products is the only integrated ultra-filtration system on the market that allows for the processing of bone marrow, peripheral blood and growth factors at the point of care. Celling Biosciences is taking autologous tissue processing to next generation medicine The scientists and engineers behind Celling Biosciences have committed themselves to developing devices, techniques and clinical processes that optimize consistent, reliable, and reproducible cell therapy solutions. The ART BMC PLUS system processes autologous bone marrow aspirate at the point of care. The recovers a high percentage of nucleated, progenitor and other cells by a selection of concentrate from a patented controlled collection system in the centrifuged stack. The integrated filter allows for the ultrafiltration of proteins from the platelet poor plasma. The ART PRP PLUS system processes autologous whole blood at the point of care. The system recovers a high percentage of platelets and growth factors by allowing a selection of concentrate from a patented controlled collection system in the centrifuged stack. The integrated filter allows for the ultrafiltration of proteins from the platelet poor plasma.